TP53 and Alzheimer disease: p53 behaviour is in agreement with our previous findings on UPS functionality; being p53 is a well-known proteasome substrate, it is reasonable that it accumulates in AD mice with impaired UPS-mediated proteolysis, and that SLAB51 administration results in decreased levels of proteasome substrates (among these p53), due to restored proteasome activities [28].